Show simple item record

dc.contributor.authorWong, Jonathan
dc.contributor.authorVilar, Enric
dc.contributor.authorDavenport, Andrew
dc.contributor.authorFarrington, Kenneth
dc.date.accessioned2017-07-07T10:11:29Z
dc.date.available2017-07-07T10:11:29Z
dc.date.issued2015-06-01
dc.identifier.citationWong , J , Vilar , E , Davenport , A & Farrington , K 2015 , ' Incremental haemodialysis ' , Nephrology Dialysis Transplantation , vol. 30 , no. 10 , pp. 1639-48 . https://doi.org/10.1093/ndt/gfv231
dc.identifier.issn0931-0509
dc.identifier.otherPURE: 10604245
dc.identifier.otherPURE UUID: ec7b21b0-3b85-43aa-95e7-bb8ed4c26c32
dc.identifier.otherPubMed: 26038351
dc.identifier.otherScopus: 84943402737
dc.identifier.urihttp://hdl.handle.net/2299/18801
dc.description© The Author 2015. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.
dc.description.abstractThrice-weekly haemodialysis schedules have become the standard default haemodialysis prescription worldwide. Whereas the measurement of residual renal function is accepted practice for peritoneal dialysis patients and the importance of residual renal function in determining technique success is well established, few centres routinely assess residual renal function in haemodialysis patients. Although intradialytic hypotension and episodes of acute kidney injury may predispose to an earlier loss of residual renal function, a significant proportion of haemodialysis patients maintain some residual function long after dialysis initiation. As such, an incremental approach to the initiation of dialysis with careful monitoring of residual renal function may potentially provide some haemodialysis patients with an improved quality of life and greater preservation of residual renal function whilst fewer dialysis sessions may reduce health care costs. Prospective trials are required to determine the optimum approach to the initiation of haemodialysis for the oliguric patient. Once residual renal function has been lost, then dialysis prescriptions should be re-examined to consider the use of longer or more frequent treatment sessions and switching from low-flux to high-flux dialysis or haemodiafiltration to offset retention of middle sized molecules and protein-bound azotaemic solutes.en
dc.format.extent10
dc.language.isoeng
dc.relation.ispartofNephrology Dialysis Transplantation
dc.subjectHumans
dc.subjectKidney Failure, Chronic
dc.subjectQuality of Life
dc.subjectRenal Dialysis
dc.subjectTime Factors
dc.titleIncremental haemodialysisen
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionDepartment of Pharmacy, Pharmacology and Postgraduate Medicine
dc.contributor.institutionBasic and Clinical Science Unit
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.description.statusPeer reviewed
dc.identifier.urlhttp://ndt.oxfordjournals.org/content/30/10/1639.long
rioxxterms.versionofrecordhttps://doi.org/10.1093/ndt/gfv231
rioxxterms.typeOther
herts.preservation.rarelyaccessedtrue


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record